Retatrutide Australia
Retatrutide research peptide available in Australia for laboratory research purposes. A triple-agonist compound targeting GLP-1, GIP and glucagon receptors, with batch-specific laboratory documentation available.
Select strength
Price
$119 AUD
Laboratory documentation
Batch Testing
Current batch
20260724
Laboratory
Not stated in report
Test date
26 July 2026
Reported purity
99.56%
Testing is arranged by Pepy and performed by independent third-party laboratories. Reports apply only to the batch shown.
View original PDFCatalogue information
Product Details
- Compound
- Retatrutide
- Strength
- 10mg
- Research classification
- Metabolic
Catalogue description
Research Information
Retatrutide is a triple receptor agonist peptide available in 10mg, 20mg and 30mg strengths. Its research context concerns combined agonism at GLP-1, GIP and glucagon receptors and the metabolic signalling pathways associated with those three receptor systems. Current batch-specific laboratory documentation is available across the listed strengths.
Read the Retatrutide research overview